Abstract:Introduction: The escalating global surge in Rifampicin-resistant strains poses a formidable challenge to the worldwide campaign against tuberculosis (TB), particularly in developing countries. The frequent reports of suboptimal treatment outcomes, complications, and the absence of definitive treatment guidelines for Rifampicin-resistant spinal TB (DSTB) contribute significantly to the obstacles in its effective management. Consequently, there is an urgent need for innovative and efficacious drugs to address Rifampicin-resistant spinal tuberculosis, minimizing the duration of therapy sessions. This study aims to investigate potential targets for DSTB through comprehensive proteomic and pharmaco-transcriptomic analyses. Methods: Mass spectrometry-based proteomics analysis was employed to validate potential DSTB-related targets. PPI analysis confirmed by Immunohistochemistry (IHC) and Western blot analysis. Results: The proteomics analysis revealed 373 differentially expressed proteins (DEPs), with 137 upregulated and 236 downregulated proteins. Subsequent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses delved into the DSTB-related pathways associated with these DEPs. In the context of network pharmacology analysis, five key targets—human leukocyte antigen A chain (HLAA), human leukocyte antigen C chain (HLA-C), HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1), metalloproteinase 9 (MMP9), and Phospholipase C-like 1 (PLCL1)—were identified as pivotal players in pathways such as "Antigen processing and presentation" and "Phagosome," which are crucially enriched in DSTB. Moreover, pharmaco-transcriptomic analysis can confirm that 58 drug compounds can regulate the expression of the key targets. Discussion: This research confirms the presence of protein alterations during the Rifampicin-resistant process in DSTB patients, offering novel insights into the molecular mechanisms underpinning DSTB. The findings suggest a promising avenue for the development of targeted drugs to enhance the management of Rifampicin-resistant spinal tuberculosis.

[Effects of the Radix Ranuncoli Ternati Extracts on Mycobacterium Tuberculosis Proteome Profiling Revealed by 2D Electrophoresis].

Identification of Differential Expression Proteins of Mycobacterium Tuberculosis Strain Isolated from Clinical Species Treated with Radix Ranuncoli Ternati Extracts by Comparative Proteomics

Comparative Proteomic and Phosphoproteomic Analysis of Mycobacteria Treated with Flavonoid Quercetin and Non-Flavonoid Caffeic Acid

Comparison of the Proteome of Mycobacterium Tuberculosis Cytosolic Basic Proteins Betwen Multiple Drugresistant Stainn and Sensitive Stains

Effects of a New Anti-Tuberculosis Compound,s28,on the Expression of Mycobacterium Tuberculosis Proteome

LC–MS-based quantitation of proteomic changes induced by Norcantharidin in MTB-Treated macrophages

Effects of Natural Rheum tanguticum on the Cell Wall Integrity of Resistant Phytopathogenic Pectobacterium carotovorum subsp. Carotovorum

Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells

Comparison of the Proteome of Isoniazid-Resistant and -Susceptible Strains Ofmycobacterium Tuberculosis

Effects against Mycobacterium tuberculosis in vivo and in vitro of a Chinese tratitional drug anti-tuberculosis pill

Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis

Analysis of Differential Expression Proteins of U937 Infected with Isoniazid-resistant MTB by Two-dimensional Electrophoresis

The Inhibition of Folylpolyglutamate Synthetase (folc) in the Prevention of Drug Resistance Inmycobacterium Tuberculosisby Traditional Chinese Medicine

Assessment of the Efficacy of the Antihistamine Drug Rupatadine Used Alone or in Combination against Mycobacteria

CRISPR Screening and Comparative LC‐MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis

Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line

Identification of protein targets of compound HY-152E with anti-tuberculosis activity using drug affinity responsive target stability technique

Proteomics study the potential targets for Rifampicin-resistant spinal tuberculosis

A Two-Way Proteome Microarray Strategy to Identify Novel Mycobacterium tuberculosis -Human Interactors.

Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis

Application of Proteomics in Traditional Chinese Medicine Research